Funder: Alliance for Cancer Gene Therapy
Due Dates: June 1, 2024 (LOI/abstract) | September 15, 2024 (Full application)
Funding Amounts: Up to $500,000 total over 2–3 years (inclusive of max 10% indirect costs).
Summary: Supports innovative research in cell and gene therapy to overcome key challenges in pancreatic cancer treatment.
Key Information: Two-step process: LOI required before full application; research must be conducted in US or Canada.